Dailypharm Live Search Close

The Minister's willingness to innovate regulations

By Lee, Hye-Kyung | translator Kim, Jung-Ju

23.02.15 14:00:01

°¡³ª´Ù¶ó 0
Visit Hanmi Pharmaceutical, which developed Rolontis, the first FDA marketing license in Korea

Emphasize global standards at New Year's meeting in the pharmaceutical sector

She met with representatives of companies and said, "I will play the role of a partner." Even the promise

 ¡ã A full view of Hanmi Pharmaceutical

Oh Yoo-kyung, head of the Ministry of Food and Drug Safety, met with representatives of pharmaceutical companies and expressed his willingness to innovate regulations.

At 2 p.m. today (15th), Director Oh met with representatives of pharmaceutical industries such as Hanmi Pharmaceutical, Dasan Pharmaceutical, Daewoong Pharmaceutical, Amgen Korea, Inist, Pfizer Korea, Huons, and Hugel at the Hanmi Pharmaceutical Research Center. The meeting was held in the name of the New Year's meeting, and the reason why Hanmi Pharmaceutical Research Center was selected as a venue is to encourage executives and employees of Hanmi Pharmaceutical, which has been approved for marketing by the U.S. FDA, for the first time i

Lee, Hye-Kyung(hgrace7@dailypharm.com)
If you want to see the full article, please JOIN US (click)